TheraRadar
Data updated: May 26, 2026

VERAPAMIL HYDROCHLORIDE

Cardiovascular Approved 1984-03-30

VERAPAMIL HYDROCHLORIDE is indicated for the treatment of Angina; Atrial Flutter; Atrial Fibrillation; Supraventricular Tachycardia; Hypertension.

Source: FDA Label • EXELA PHARMA
43
Indications
--
Phase 3 Trials
42
Years on Market

VERAPAMIL HYDROCHLORIDE Approval History

1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
816 FDA actions from 1984 to 2025
Nov 2025 ORIGINAL
Update
Nov 2025 ORIGINAL
Update
Sep 2025 SUPPL
Label · Labeling

What VERAPAMIL HYDROCHLORIDE Treats

5 indications

VERAPAMIL HYDROCHLORIDE is approved for 5 conditions since its original approval in 1984. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Angina
  • Atrial Flutter
  • Atrial Fibrillation
  • Supraventricular Tachycardia
  • Hypertension
Source: FDA Label

VERAPAMIL HYDROCHLORIDE Competitive Set

Pro

Three rings of competition based on shared molecular targets and treated indications.

Unlock 8 more competitors across all three rings.
Upgrade to Pro

Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.

Drugs Similar to VERAPAMIL HYDROCHLORIDE

3 of 20

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

VERELAN
VERAPAMIL HYDROCHLORIDE
5 shared
AZURITY
Shared indications:
BREVIBLOC DOUBLE STRENGTH IN PLASTIC CONTAINER
ESMOLOL HYDROCHLORIDE
4 shared
Baxter
BREVIBLOC IN PLASTIC CONTAINER
ESMOLOL HYDROCHLORIDE
4 shared
Baxter
📋

Clinical Trial Registry

2 trials
Trial Sponsor ID Phase Status Title
NCT03013933 16414 NCI-2016-02062, 16414 Ph 1 completed Brentuximab Vedotin, Cyclosporine, and Verapamil Hydrochloride in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
NCT03098680 PRIME PRIME (A094136) Ph 1 terminated A Study of the Pharmacokinetic and Pharmacodynamic Responses in Healthy and Altered Human Cardiovascular Systems
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

VERAPAMIL HYDROCHLORIDE FDA Label Details

Indications & Usage

FDA Label (PDF)

VERAPAMIL HYDROCHLORIDE is indicated for the treatment of Angina; Atrial Flutter; Atrial Fibrillation; Supraventricular Tachycardia; Hypertension.

Looking for the branded version?

VERELAN PM

Full clinical data, patents, trials, and competitive landscape for verapamil hydrochloride.

See VERELAN PM

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.